Form 4: Precigen Director Sells 1.8M Shares
Insider Transaction Report
Precigen Director and 10% owner Randal J. Kirk reported the direct sale of 1,809,667 shares of common stock at a weighted average price of $3.41.
Summary
- Randal J. Kirk, a Director and 10% owner of Precigen, Inc. (PGEN), reported the direct sale of 1,809,667 shares of common stock.
- The transaction occurred on September 30, 2025, at a weighted average price of $3.41 per share, with individual sales ranging from $3.35 to $3.62.
- This sale was not made pursuant to a Rule 10b5-1 pre-arranged trading plan.
- Following the transaction, Mr. Kirk indirectly beneficially owns a total of 127,012,553 shares through various controlled entities and his spouse, while disclaiming beneficial ownership except for pecuniary interest.
Sentiment
Score: 3
Explanation: The sale of a significant number of shares by a Director and 10% owner, Randal J. Kirk, particularly when not part of a pre-arranged 10b5-1 plan, is typically viewed as a negative signal by the market, suggesting a discretionary decision to reduce exposure.
Negatives
- A Director and 10% owner, Randal J. Kirk, directly disposed of a substantial 1,809,667 shares of common stock.
- The sale was not executed under a Rule 10b5-1 trading plan, suggesting a discretionary transaction rather than a pre-scheduled one.
- Insider selling by a significant shareholder and director can be interpreted by the market as a negative signal regarding the company's near-term prospects or valuation.
Risks
- Potential negative market perception due to significant insider selling by a Director and 10% owner, which could lead to downward pressure on the stock price.
Future Outlook
No forward-looking statements or guidance are provided in this insider transaction report.
Management Comments
- Randal J. Kirk disclaims beneficial ownership of such shares (indirectly held), except to the extent of any pecuniary interest therein.
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders may perceive the insider sale negatively, potentially leading to downward pressure on the stock price due to concerns about management's confidence or valuation.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of earliest transaction (sale of common stock by Randal J. Kirk) |
Recommendation
holdThe significant sale of shares by a Director and 10% owner, Randal J. Kirk, not under a 10b5-1 plan, is a negative signal that could indicate a lack of confidence or personal liquidity needs. However, as this represents a relatively small portion of his total beneficial ownership, a 'hold' recommendation is prudent. Investors should monitor future insider activity and company performance for a clearer picture before making a definitive buy or sell decision.
Keywords
Precigen, PGEN, Randal J. Kirk, Insider Trading, Form 4, Stock Sale, Beneficial Ownership, Director, 10% Owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.